Corruption exposed: drug companies gave grants, consulting fees to panelists who issued new cholesterol guidelines that are driving demand for statins
The new cholesterol lowering guidelines are proving to be a windfall for statin drug manufacturers like Pfizer and Merck: most news articles and medical advice concerning the new guidelines recommend drugs -- and drugs only -- to reduce cholesterol level. As a result, the guidelines are perhaps better described as profit generators for pharmaceutical companies.